Chapter 26: Penicillins, Beta-Lactams & Cephalosporins

A primary focus is placed on the mechanism of antibacterial action, specifically how beta-lactam agents inhibit bacterial cell wall synthesis to induce cell lysis and bactericidal effects. The discussion details the evolution of penicillins from basic natural forms like penicillin G and V to broad-spectrum aminopenicillins such as amoxicillin, penicillinase-resistant antistaphylococcal agents, and extended-spectrum antipseudomonal drugs like piperacillin. To address the critical issue of bacterial resistance—including the emergence of Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VREF)—the chapter explains the function of beta-lactamase inhibitors like clavulanic acid, sulbactam, and tazobactam in restoring antibiotic efficacy. The narrative further examines the five generations of cephalosporins, delineating how each successive generation offers expanded gram-negative coverage, increased resistance to beta-lactamase enzymes, and improved cerebrospinal fluid penetration, culminating in fifth-generation agents effective against resistant strains like MRSA. Other beta-lactam classes, such as carbapenems (imipenem, meropenem) and monobactams (aztreonam), are reviewed for their utility in severe infections. Pharmacokinetic factors, including protein binding and renal excretion, are linked to pharmacodynamic principles like minimum effective concentration. The summary concludes with essential nursing process considerations, emphasizing the management of hypersensitivity reactions and anaphylaxis, the risk of cross-sensitivity between beta-lactams, the prevention of superinfections such as Clostridium difficile-associated diarrhea, and the necessity of culture and sensitivity testing to guide appropriate therapeutic interventions.